Center of Excellence for Pulmonary Hypertension
At the Center of Excellence for Pulmonary Hypertension, we specialize in:
-
Pulmonary artery hypertension (PAH)
-
Chronic Thromboembolic Pulmonary Hypertension - screening for PAH after an acute episode at third month after proper anticoagulation, once a year
-
Systemic sclerosis - screening for PAH once a year or more
Our specialists also prepare patients for liver transplantation (screening for portopulmonary hypertension). Moreover, patients with a family history of idiopathic or hereditary PAH and/or mutations associated with hereditary PAH are treated at our center. The list of services provided at CEPH:
-
qualified consultations of a cardiologist, pediatric cardiologist, pulmonologist, and other specialists,
-
psychological assistance is provided to patients: counseling, coping with an emotional crisis, supportive therapy, relaxation techniques, rehabilitation treatment.
Diagnostic and treatment issues for patients are addressed in physician discussions every week.
We conduct biomedical research:
-
Project initiated by the European Society of Cardiology: Pregnancy & Heart Disease Registry ROPAC: 2009 – 2011 m: ROPAC I; 2012-2017 ROPAC II.
-
Member of the European Scleroderma Trials and Research group (EUSTAR). Minimum Essential Data set (MEDS) multicenter project. (R. Rugienė, from 2011)
-
European Respiratory Society Working Group: Pulmonary rehabilitation for PAH.
-
Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension – Compera
-
Surveillance study of the patients with rare heart diseases and large arterial and lung diseases (from 2020)
